Johnson and Johnson Newswire (Page 5)

Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 19,667 in Johnson and Johnson

  1. Investigation casts doubt over trial used to support top-selling anti-clotting drugRead the original story w/Photo

    Wednesday Feb 3 | Medical News Today

    ... to clarify the drug's benefits and harms. Rivaroxaban, manufactured by Bayer and marketed in the US by Johnson and Johnson, belongs to a class of medicines known as the 'direct oral anticoagulants' (DOACs). It works by preventing blood from clotting ...

    Comment?

  2. Market Valuations and Expected Returns Jan. 2016Read the original story w/Photo

    Wednesday Feb 3 | GuruFocus.com

    The market had its worst January in many years. This has generated quite some fear in the market and has prompted Howard Marks written two memos in January: On the Coach and What Does the Market Know? We strongly recommend you to read both if you haven't done so.

    Comment?

  3. Seattle theater to stage play about Tylenol murdersRead the original story w/Photo

    Wednesday Feb 3 | Daily Herald

    A small theater in suburban Seattle will stage a new play next month about the 1982 Tylenol cyanide poisonings, which killed six people from the suburbs and a Chicago woman. Writer and director Alan Bryce, who grew up in London and has no ties to Chicago, said he was inspired to write the play, "Death on the Supermarket Shelf," after reading the self-published 2011 book, "The Tylenol Mafia: Marketing, Murder, and Johnson & Johnson," by Scott Bartz .

    Comment?

  4. Johnson & Johnson CEO buys $9 million Manhattan condo :0Read the original story w/Photo

    Wednesday Feb 3 | New York Post

    Alex Gorsky, the CEO of Johnson & Johnson, and his wife, Patricia, bought a $9 million condo at One Riverside Park, an Extell Development project at 50 Riverside Drive - well over its $8.86 million asking price, according to city property records. In 2013, Johnson & Johnson agreed to pay $2.2 billion in criminal and civil fines for improperly promoting the anti-psychotic drug Risperdal to older adults with dementia in nursing homes, children, and people with developmental disabilities.

    Comment?

  5. Big Pharma??'s Business Model Goes Under The MicroscopeRead the original story

    Tuesday Feb 2 | BioSpace

    Some of the world's biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour of greater focus as shareholders push for higher returns on investment.

    Comment?

  6. How Big Is Too Big for Medical Device Companies?Read the original story

    Tuesday Feb 2 | BioSpace

    Johnson & Johnson is not alone when it comes to calls for it to spin off its medical device businesses. Novartis has been questioned over the future of its struggling Alcon eye treatments business, and Pfizer and GlaxoSmithKline face pressure to break up, according to the Financial Times.

    Comment?

  7. Big Names Like Johnson & Johnson, Merck & Co. and Pfizer Evaluate...Read the original story

    Tuesday Feb 2 | BioSpace

    Pfizer Inc , Johnson and Johnson and Merck & Co Inc said they were evaluating their technologies or existing vaccines for their potential to combat Zika, a rapidly spreading mosquito-borne disease linked to birth defects. A number of drug developers and universities are attempting to produce a vaccine for Zika, which the World Health Organization has declared an international health emergency.

    Comment?

  8. Will Johnson & Johnson's Plan To Retool Its Medical Device Business Succeed?Read the original story

    Thursday Jan 28 | BioSpace

    Big changes are afoot in the medical device industry, and Johnson & Johnson is in the driver's seat. When the largest among medical device companies makes a move, the industry tends to stop and pay attention.

    Comment?

  9. Johnson & Johnson (JNJ) is Atlas Brown Inc.'s 3rd Largest PositionRead the original story w/Photo

    Wednesday Feb 3 | Daily Political

    Atlas Brown Inc. reduced its stake in Johnson & Johnson by 0.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm owned 33,506 shares of the company's stock after selling 72 shares during the period.

    Comment?

  10. Odis TateRead the original story

    Wednesday Feb 3 | MainStreetNews.com

    Odis Tate, 89, entered into rest Wednesday, February 3, 2016. Mr. Tate was born in Talmo, the son of the late Thomas R. and Julie Hulsey Tate.

    Comment?

  11. Exxon Mobil nearly stripped of AAA ratingRead the original story w/Photo

    Wednesday Feb 3 | USA Today

    Only three U.S. companies get the perfect AAA credit rating. But one of those is looking shakier and could be stripped Exxon Mobil nearly stripped of AAA rating Only three U.S. companies get the perfect AAA credit rating.

    Comment?

  12. 'Get a Job' Trailer: Anna Kendrick, Miles Teller Look for WorkRead the original story w/Photo

    Wednesday Feb 3 | Hollywood Reporter

    In the trailer for Get a Job , the Pitch Perfec t actress and Whiplash star play Jillian and Will, two millennials in the job market dealing with cyclical unemployment and student loan debt, as millennials in the job market often do. Just as Will loses his job at LA Weekly , Jillian begins a great job Johnson & Johnson.

    Comment?

  13. Chipotle Earnings: Look Beyond These Hideous NumbersRead the original story

    Wednesday Feb 3 | US News & World Report

    Chipotle's fourth-quarter earnings report, issued after the market closed Tuesday, had shares of the embattled stock falling by more than 5 percent in after-hours trading. The numbers were ugly, but expectedly so - after all, Chipotle was dealing with E. coli and norovirus outbreaks for most of the quarter.

    Comment?

  14. Scientists Piggyback Experimental HIV Vaccine on Cold VirusesRead the original story w/Photo

    Tuesday Feb 2 | MedlinePlus

    In the new study, Harvard researchers said they successfully used cold viruses to deliver an experimental HIV vaccine to humans. The approach "appears to be safe and well-tolerated, and the injection induces a moderate immune response against HIV in humans," said Dr. James Crowe, director of Vanderbilt Vaccine Center in Nashville.

    Comment?

  15. AlphaMark Advisors LLC Has $502,000 Position in Johnson & JohnsonRead the original story w/Photo

    Wednesday Feb 3 | AmericanBankingNews.com

    AlphaMark Advisors LLC held its position in Johnson & Johnson during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,883 shares of the company's stock at the end of the fourth quarter.

    Comment?

  16. Just Published: 'Thermoplastic Vulcanizates (TPV) Market 2015-2019'Read the original story w/Photo

    Wednesday Feb 3 | PR-inside.com

    Technavio's market research analyst predicts the thermoplastic vulcanizates market to grow at a rate of around 7% during the forecast period. The rising adoption of TPV as a replacement for PVC in the healthcare sector is the primary driver for the growth of this market.

    Comment?

  17. Johnson & Johnson (JNJ) Shares Sold by Addison Capital CoRead the original story w/Photo

    Wednesday Feb 3 | Daily Political

    Addison Capital Co reduced its position in Johnson & Johnson by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,634 shares of the company's stock after selling 434 shares during the period.

    Comment?

  18. Mifold Raises $1.5 Million For Its Grab-And-Go Booster SeatRead the original story w/Photo

    Wednesday Feb 3 | TechCrunch

    If you have young children, or your children aren't so old that you can still remember what a complete and utter pain clunky car seats can be, you might want to acquaint yourself with three-year-old, Ra'anana, Israel-based mifold . The founders of King Digital Entertainment did.

    Comment?

  19. Johnson & Johnson (NYSE:JNJ) Given Average Recommendation of "Hold" by AnalystsRead the original story w/Photo

    Tuesday Feb 2 | Daily Political

    Johnson & Johnson has been assigned an average recommendation of "Hold" from the twenty-one ratings firms that are covering the firm, AnalystRatings.NET reports . One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have given a buy rating to the company.

    Comment?

  20. Israel Pic: Full Moon over Har Hotzvim JerusalemRead the original story w/Photo

    Thursday Jan 14 | Mystical Paths

    Israel is an incredible land, the Holy Land. Whether it's natural views changing from beach to desert to lake to mountains, or holy places, or ancient ruins, or modern technology parks, every bit of Israel presents stunning views.

    Comment?